Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2

Kim,Tae‑Hun; Cho,Sung‑Gook

doi:10.3892/mmr.2017.7578

Kisspeptin inhibits cancer growth and metastasis via activation of EIF2AK2

Authors:
- Tae‑Hun Kim
- Sung‑Gook Cho
View Affiliations

Affiliations: Department of Biotechnology, Korea National University of Transportation, Jeungpyong, Chungbuk 368‑701, Republic of Korea
Published online on: September 21, 2017 https://doi.org/10.3892/mmr.2017.7578
Pages: 7585-7590

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Kisspeptin is a protein encoded by the KISS1 gene, which has been reported to suppress the metastatic capabilities of various types of cancer cells, through the activation of its G‑protein coupled receptor GPR54. However, the molecular mechanisms underlying the involvement of kisspeptin‑mediated signaling in the inhibition of cancer cell migration and invasion have yet to be elucidated. The present in vitro cell proliferation, migration and invasion assays and in vivo experimental metastasis studies demonstrated that kisspeptin‑induced eukaryotic translation initiation factor 2α kinase 2 (EIF2AK2) activation suppressed the metastatic capabilities of several types of cancer cells. Kisspeptin was revealed to inhibit the migratory and invasive abilities of highly metastatic breast SK‑BR‑3, prostatic PC‑3 and colorectal adenocarcinoma LoVo human cancer cell lines, whereas its inhibitory effects were abolished following the silencing of EIF2AK2 expression using RNA interference. Similarly, kisspeptin failed to inhibit the migration and invasion of mouse embryonic fibroblasts following the deletion of the EIF2AK2 gene. Furthermore, kisspeptin was demonstrated to activate Ras homolog gene family member A (RhoA)‑dependent signaling, and to phosphorylate EIF2AK2 via RhoA‑mediated pathways in various cancer cells. In addition, results obtained from nude mice bearing LoVo‑derived xenograft tumors revealed that kisspeptin inhibited tumor growth through an EIF2AK2‑dependent mechanism, and an in vivo metastasis assay identified kisspeptin‑activated EIF2AK2 signaling as critical for the suppression of distant metastasis. The present study concluded that kisspeptin represses cancer metastasis via EIF2AK2 signaling, thus clarifying the role of kisspeptin signaling in complicated cancer metastasis signaling network. Therefore, kisspeptin treatment may be a choice for blocking metastases.

View Figures

View References

1	Oakley AE, Clifton DK and Steiner RA: Kisspeptin signaling in the brain. Endocr Rev. 30:713–743. 2009. View Article : Google Scholar : PubMed/NCBI
2	Colledge WH, Doran J and Mei H: Model systems for studying kisspeptin signalling: Mice and cells. Adv Exp Med Biol. 784:481–503. 2013. View Article : Google Scholar : PubMed/NCBI
3	Silveira LG, Latronico AC and Seminara SB: Kisspeptin and clinical disorders. Adv Exp Med Biol. 784:187–199. 2013. View Article : Google Scholar : PubMed/NCBI
4	Castellano JM and Tena-Sempere M: Metabolic regulation of kisspeptin. Adv Exp Med Biol. 784:363–383. 2013. View Article : Google Scholar : PubMed/NCBI
5	Cho SG, Li D, Tan K, Siwko SK and Liu M: KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis. Cancer Metastasis Rev. 31:585–591. 2012. View Article : Google Scholar : PubMed/NCBI
6	Lee JH and Welch DR: Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1. Cancer Res. 57:2384–2387. 1997.PubMed/NCBI
7	Ohtaki T, Shintani Y, Honda S, Matsumoto H, Hori A, Kanehashi K, Terao Y, Kumano S, Takatsu Y, Masuda Y, et al: Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 411:613–617. 2001. View Article : Google Scholar : PubMed/NCBI
8	Navenot JM, Fujii N and Peiper SC: Activation of Rho and Rho-associated kinase by GPR54 and KiSS1 metastasis suppressor gene product induces changes of cell morphology and contributes to apoptosis. Mol Pharmacol. 75:1300–1306. 2009. View Article : Google Scholar : PubMed/NCBI
9	Tan K, Cho SG, Luo W, Yi T, Wu X, Siwko S, Liu M and Yuan W: KiSS1-induced GPR54 signaling inhibits breast cancer cell migration and epithelial-mesenchymal transition via protein kinase D1. Curr Mol Med. 14:652–662. 2014. View Article : Google Scholar : PubMed/NCBI
10	Jiang Y, Berk M, Singh LS, Tan H, Yin L, Powell CT and Xu Y: KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha. Clin Exp Metastasis. 22:369–376. 2005. View Article : Google Scholar : PubMed/NCBI
11	Roseweir AK, Katz AA and Millar RP: Kisspeptin-10 inhibits cell migration in vitro via a receptor-GSK3 beta-FAK feedback loop in HTR8SVneo cells. Placenta. 33:408–415. 2012. View Article : Google Scholar : PubMed/NCBI
12	Cho SG, Li D, Stafford LJ, Luo J, Rodriguez-Villanueva M, Wang Y and Liu M: KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. J Cell Biochem. 107:1139–1149. 2009. View Article : Google Scholar : PubMed/NCBI
13	Stafford LJ, Xia C, Ma W, Cai Y and Liu M: Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor. Cancer Res. 62:5399–5404. 2002.PubMed/NCBI
14	Williams BR: PKR; a sentinel kinase for cellular stress. Oncogene. 18:6112–6120. 1999. View Article : Google Scholar : PubMed/NCBI
15	Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG: Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA. 90:232–236. 1993; View Article : Google Scholar : PubMed/NCBI
16	Hii SI, Hardy L, Crough T, Payne EJ, Grimmett K, Gill D and McMillan NA: Loss of PKR activity in chronic lymphocytic leukemia. Int J Cancer. 109:329–335. 2004. View Article : Google Scholar : PubMed/NCBI
17	Shir A and Levitzki A: Inhibition of glioma growth by tumor-specific activation of double-stranded RNA-dependent protein kinase PKR. Nat Biotechnol. 20:895–900. 2002. View Article : Google Scholar : PubMed/NCBI
18	Watanabe MA, Souza L Rodrigues, Murad JM and De Lucca FL: Antitumor activity induced by regulatory RNA: Possible role of RNA-dependent protein kinase and nuclear factor-kappaB. Eur J Pharmacol. 465:205–210. 2003. View Article : Google Scholar : PubMed/NCBI
19	Kim SH, Gunnery S, Choe JK and Mathews MB: Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene. 21:8741–8748. 2002. View Article : Google Scholar : PubMed/NCBI
20	Kim SH, Forman AP, Mathews MB and Gunnery S: Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene. 19:3086–3094. 2000. View Article : Google Scholar : PubMed/NCBI
21	Haines GK, Cajulis R, Hayden R, Duda R, Talamonti M and Radosevich JA: Expression of the double-stranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol. 17:5–12. 1996. View Article : Google Scholar : PubMed/NCBI
22	Savinova O, Joshi B and Jagus R: Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int J Biochem Cell Biol. 31:175–189. 1999. View Article : Google Scholar : PubMed/NCBI
23	Xu M, Chen G, Wang S, Liao M, Frank JA, Bower KA, Zhang Z, Shi X and Luo J: Double-stranded RNA-dependent protein kinase regulates the motility of breast cancer cells. PLoS One. 7:e477212012. View Article : Google Scholar : PubMed/NCBI
24	Yuan X, Wang W, Li J, Zheng P, Dong P, Chen L, Zhou Y, Xie G, Xu D, Liu Y and Shen L: Gelsolin suppresses gastric cancer metastasis through inhibition of PKR-p38 signaling. Oncotarget. 7:53459–53470. 2016. View Article : Google Scholar : PubMed/NCBI
25	Wang X, Dong JH, Zhang WZ, Leng JJ, Cai SW, Chen MY and Yang X: Double stranded RNA-dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3. Oncol Lett. 8:2762–2768. 2014.PubMed/NCBI
26	Irving AT, Wang D, Vasilevski O, Latchoumanin O, Kozer N, Clayton AH, Szczepny A, Morimoto H, Xu D, Williams BR and Sadler AJ: Regulation of actin dynamics by protein kinase R control of gelsolin enforces basal innate immune defense. Immunity. 36:795–806. 2012. View Article : Google Scholar : PubMed/NCBI
27	Cho SG, Wang Y, Rodriguez M, Tan K, Zhang W, Luo J, Li D and Liu M: Haploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasis. Cancer Res. 71:6535–6546. 2011. View Article : Google Scholar : PubMed/NCBI
28	Shengbing Z, Feng LJ, Bin W, Lingyun G and Aimin H: Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma. Anat Rec (Hoboken). 292:1128–1134. 2009. View Article : Google Scholar : PubMed/NCBI
29	Caino MC, Chae YC, Vaira V, Ferrero S, Nosotti M, Martin NM, Weeraratna A, O'Connell M, Jernigan D, Fatatis A, et al: Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells. J Clin Invest. 123:2907–2920. 2013. View Article : Google Scholar : PubMed/NCBI
30	Pietrocola F, Izzo V, Niso-Santano M, Vacchelli E, Galluzzi L, Maiuri MC and Kroemer G: Regulation of autophagy by stress-responsive transcription factors. Semin Cancer Biol. 23:310–322. 2013. View Article : Google Scholar : PubMed/NCBI
31	Mackeh R, Perdiz D, Lorin S, Codogno P and Poüs C: Autophagy and microtubules-new story, old players. J Cell Sci. 126:1071–1080. 2013. View Article : Google Scholar : PubMed/NCBI